US obesity rates may be turning around — driven by Ozempic and Wegovy

After years of steady increases, US obesity rates are showing early signs of levelling off or declining. Researchers point to the rapid rise in use of weight-loss drugs such as Ozempic and Wegovy as a likely factor. However, scientists caution it is too early to declare a lasting turning point.